ALKYLATION OF ESCHERICHIA-COLI THIOREDOXIN BY S-(2-CHLOROETHYL) GLUTATHIONE AND IDENTIFICATION OF THE ADDUCT ON THE ACTIVE-SITE CYSTEINE-32 BY MASS-SPECTROMETRY

被引:17
作者
ERVE, JCL
BAROFSKY, E
BAROFSKY, DF
DEINZER, ML
REED, DJ
机构
[1] OREGON STATE UNIV,DEPT BIOCHEM & BIOPHYS,CORVALLIS,OR 97331
[2] OREGON STATE UNIV,DEPT AGR CHEM,CORVALLIS,OR 97331
关键词
D O I
10.1021/tx00049a006
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Alkylation of reduced Escherichia coli thioredoxin by the episulfonium ion derived from S-(2-chloroethyl)glutathione (CEG) at physiologic pH resulted in at least three different alkylation products. These adducts were separated by reverse phase chromatography, digested with trypsin, and peptide-mapped. The peptide containing the active site cysteines was collected and sequenced by tandem mass spectrometry. Results indicate that the site of alkylation was at Cys-32 exclusively with no alkylation at Cys-35. Raising the pH above the pK(a) of Cys-35 to ionize the thiol before reacting with the episulfonium ion of CEG did not lead to alkylation at Cys-35, suggesting that a steric factor prevents the alkylating moiety of CEG from accessing this cysteine. A tryptic digest of a minor bis-adduct yielded an alkylated peptide which contained tyrosine, an amino acid known to be alkylated at its hydroxyl group by CEG. Sequencing by tandem mass spectrometry, however, was unsuccessful due to fragmentation of the alkylating moiety from the peptide. Results of this study confirm that the episulfonium ion of CEG can adduct thioredoxin at the active site and may have important toxicologic significance regarding the mechanism of 1,2-dichloroethane toxicity.
引用
收藏
页码:934 / 941
页数:8
相关论文
共 43 条
[1]  
BANERJEE S, 1980, CANCER RES, V40, P2170
[2]   CONTRIBUTIONS OF MASS-SPECTROMETRY TO PEPTIDE AND PROTEIN-STRUCTURE [J].
BIEMANN, K .
BIOMEDICAL AND ENVIRONMENTAL MASS SPECTROMETRY, 1988, 16 (1-12) :99-111
[3]  
BIGUET C, 1994, J BIOL CHEM, V269, P28865
[4]   THIOREDOXIN - A MULTIFUNCTIONAL REGULATORY PROTEIN WITH A BRIGHT FUTURE IN TECHNOLOGY AND MEDICINE [J].
BUCHANAN, BB ;
SCHURMANN, P ;
DECOTTIGNIES, P ;
LOZANO, RM .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1994, 314 (02) :257-260
[5]  
BURNS JA, 1991, J ORG CHEM, V16, P99
[6]   CENTRIFUGAL SIZE-EXCLUSION CHROMATOGRAPHIC METHOD FOR RAPID DESALTING AND FILTERING OF CARBOHYDRATE SAMPLES PRIOR TO FAST-ATOM-BOMBARDMENT MASS-SPECTROMETRY [J].
CHEN, TF ;
YU, HN ;
BAROFSKY, DF .
ANALYTICAL CHEMISTRY, 1992, 64 (17) :2014-2019
[7]   THE BINDING OF AN AMINOAZO DYE CARCINOGEN TO A SPECIFIC METHIONINE RESIDUE IN RAT-LIVER ALCOHOL-DEHYDROGENASE INVIVO [J].
COLES, B ;
BEALE, D ;
MILLER, D ;
LAY, J ;
KADLUBAR, F ;
AITKEN, A ;
KETTERER, B .
CHEMICO-BIOLOGICAL INTERACTIONS, 1987, 64 (1-2) :181-192
[8]   BIOACTIVATION OF NEPHROTOXIC HALOALKENES BY GLUTATHIONE CONJUGATION - FORMATION OF TOXIC AND MUTAGENIC INTERMEDIATES BY CYSTEINE CONJUGATE BETA-LYASE [J].
DEKANT, W ;
VAMVAKAS, S .
DRUG METABOLISM REVIEWS, 1989, 20 (01) :43-83
[9]   3-DIMENSIONAL SOLUTION STRUCTURE OF THE REDUCED FORM OF ESCHERICHIA-COLI THIOREDOXIN DETERMINED BY NUCLEAR-MAGNETIC-RESONANCE SPECTROSCOPY [J].
DYSON, HJ ;
GIPPERT, GP ;
CASE, DA ;
HOLMGREN, A ;
WRIGHT, PE .
BIOCHEMISTRY, 1990, 29 (17) :4129-4136
[10]   EVALUATION OF GENETIC RISKS OF ALKYLATING-AGENTS .3. ALKYLATION OF HEMOGLOBIN AFTER METABOLIC CONVERSION OF ETHENE TO ETHENE OXIDE INVIVO [J].
EHRENBERG, L ;
OSTERMANGOLKAR, S ;
SEGERBACK, D ;
SVENSSON, K ;
CALLEMAN, CJ .
MUTATION RESEARCH, 1977, 45 (02) :175-184